Journal article
O. O. Shiyanbola, A. Tarfa, A. Song, L. K. Sharp, E. Ward
Health Behavior and Policy Review, 6(6), 2019, pp. 558- 569
Health Behavior and Policy Review, 6(6), 2019, pp. 558- 569
Cite
Cite
APA
Click to copy
Shiyanbola, O. O., Tarfa, A., Song, A., Sharp, L. K., & Ward, E. (2019). Preliminary feasibility of a peer-supported diabetes medication adherence intervention for African Americans. Health Behavior and Policy Review, 6(6), 558–569. https://doi.org/10.1186/s40814-022-01198-7
Chicago/Turabian
Click to copy
Shiyanbola, O. O., A. Tarfa, A. Song, L. K. Sharp, and E. Ward. “Preliminary Feasibility of a Peer-Supported Diabetes Medication Adherence Intervention for African Americans.” Health Behavior and Policy Review 6, no. 6 (2019): 558–569.
MLA
Click to copy
Shiyanbola, O. O., et al. “Preliminary Feasibility of a Peer-Supported Diabetes Medication Adherence Intervention for African Americans.” Health Behavior and Policy Review, vol. 6, no. 6, 2019, pp. 558–69, doi:10.1186/s40814-022-01198-7.
BibTeX Click to copy
@article{shiyanbola2019a,
title = {Preliminary feasibility of a peer-supported diabetes medication adherence intervention for African Americans},
year = {2019},
issue = {6},
journal = {Health Behavior and Policy Review},
pages = {558- 569},
volume = { 6},
doi = {10.1186/s40814-022-01198-7},
author = {Shiyanbola, O. O. and Tarfa, A. and Song, A. and Sharp, L. K. and Ward, E.}
}
Abstract
African Americans are twice as likely to die from diabetes, compared to other racial and ethnic groups in the USA. Poor adherence to diabetes medications is common among African Americans and contributes to these disproportionally worse outcomes. A pilot study was conducted to determine the feasibility and acceptability of a peer-supported intervention targeting diabetes and medication beliefs, communication, and self-efficacy skills to enhance medication adherence among African Americans with type 2 diabetes.
Most buddies and ambassadors were female and about 56 years old. Feasibility outcomes included recruitment success rates of 73% for buddies and 85% for ambassadors relative to our goals. Retention rate for hemoglobin A1c and medication adherence outcome assessment was 95% for buddies. Both buddies and ambassadors had excellent intervention adherence, with buddies having a mean attendance of 7.76 out of 8 sessions/phone calls and ambassadors completing > 99% of the 105 intervention calls with Buddies. Results showed a signal of change in hemoglobin A1c (effect size = 0.14) and medication adherence (effect size = 0.35) among buddies, reduction in buddies’ negative beliefs about diabetes and an increase in necessity beliefs of diabetes medicines. Summative interviews with buddies showed they valued ambassador’s encouragement of self-management behaviors.
Results support conduct of an efficacy trial to address medication adherence for African Americans with type 2 diabetes using a peer-supported tailored intervention.
